Purification and Characterization of Human Chorionic Gonadotropin

Endocrinology ◽  
1969 ◽  
Vol 84 (2) ◽  
pp. 298-307 ◽  
Author(s):  
JENNIFER J. BELL ◽  
ROBERT E. CANFIELD ◽  
JOHN J. SCIARRA
FEBS Letters ◽  
1971 ◽  
Vol 15 (1) ◽  
pp. 33-35 ◽  
Author(s):  
R. Brossmer ◽  
M. Dörner ◽  
U. Hilgenfeldt ◽  
F. Leidenberger ◽  
E. Trude

1999 ◽  
Vol 45 (1) ◽  
pp. 68-77 ◽  
Author(s):  
Galina Kovalevskaya ◽  
Steven Birken ◽  
Tatsu Kakuma ◽  
John Schlatterer ◽  
John F O’Connor

Abstract We report the development and characterization of an IRMA for the direct measurement of nicked human chorionic gonadotropin (hCGn) in blood and urine. hCGn derived from a reference preparation of hCG used as an immunogen elicits monoclonal antibodies (mAbs) with enhanced recognition of human luteinizing hormone epitopes. The most specific assay for pregnancy hCGn is an IRMA composed of one mAb to choriocarcinoma-derived hCGn (C5) and a second mAb developed from immunization with normal-pregnancy hCGn. This assay was used to evaluate hCGn profiles in normal, in vitro fertilization, Down syndrome, and ectopic pregnancies. In all pregnancies, hCGn was usually present in much lower concentrations than the non-nicked hCG isoform. Our results suggest that some form of physical separation from the overwhelming quantities of non-nicked hCG present in clinical specimens will be required before accurate immunochemical estimations of hCGn can be made.


Sign in / Sign up

Export Citation Format

Share Document